H6H
ABBV icon

Hightower 6M Holding’s AbbVie ABBV Stock Holding History

Hightower 6M Holding’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$6.93M Buy
51,651
+24,318
+89% +$3.49M 0.62% 22
2022
Q2 		$4.19M Sell
27,333
-250
-0.9% -$38.2K 0.35% 46
2022
Q1 		$4.47M Buy
+27,583
New +$4.01M 0.34% 50

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hightower 6M Holding's ABBV Position: Q3 2022 in Review

Hightower 6M Holding increased its AbbVie (ABBV) stake by 89% in Q3 2022, buying an estimated $3.49M and bringing the position to 51,651 shares worth $6.93M. The position accounts for 0.62% of the portfolio, ranked #22.

Hightower 6M Holding first reported a position in ABBV in Q1 2022 and has held it in 3 quarters since. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Hightower 6M Holding held 51,651 shares of AbbVie worth $6.93M as of Q3 2022.
  • Hightower 6M Holding bought 24,318 AbbVie shares in Q3 2022, an estimated $3.49M.
  • AbbVie made up 0.62% of Hightower 6M Holding's portfolio in Q3 2022, its #22 holding.
  • Hightower 6M Holding first reported a position in AbbVie in Q1 2022 and has held it in 3 quarters since.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.